Nothing Special   »   [go: up one dir, main page]

CN104419684A - Construction of 18-trisomy syndrome cell model and cell bank of 18-trisomy syndrome cell by SV40LT gene transfection - Google Patents

Construction of 18-trisomy syndrome cell model and cell bank of 18-trisomy syndrome cell by SV40LT gene transfection Download PDF

Info

Publication number
CN104419684A
CN104419684A CN201310415253.0A CN201310415253A CN104419684A CN 104419684 A CN104419684 A CN 104419684A CN 201310415253 A CN201310415253 A CN 201310415253A CN 104419684 A CN104419684 A CN 104419684A
Authority
CN
China
Prior art keywords
cell
trisomy
dna
growth
bank
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310415253.0A
Other languages
Chinese (zh)
Inventor
翁炳焕
黄荷凤
陈松长
李晓
刘蓓
陈雁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310415253.0A priority Critical patent/CN104419684A/en
Publication of CN104419684A publication Critical patent/CN104419684A/en
Pending legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention relates to construction of an 18-trisomy syndrome cell model and a cell bank of 18-trisomy syndrome cell by SV40LT gene transfection for the field of medical research. The construction is mainly characterized in that an SV40LTag-pcDNA3.1(-) recombinant is constructed through a T4DNA ligase, BamHI, pcDNA3.1(-) DNA and SV40LTag DNA as a matter of routine, the recombinant is purified through competent escherichia coli, the recombinant is introduced into an in-vitro passage cell digested through collagenase II or an 18-trisomy syndrome tissue cell which is logarithmically grown through a lipoid transfection method to be integrated with cell DNA, and a cloned cell which is screened through G418 and contains a positive recombinant is subjected to amplification culture; and a cell which accords with the characteristics of an immortalized cell and is the same as or similar to a primary cell on a cell morphology, a growth curve, a chromosome karyotype, soft agar colony growth, a nude mouse tumorigenesis test, SV40 large T gene detection of transfection cell DNA, an mRNA expression product measurement result and a DNA sequence measurement result is screened as the 18-trisomy syndrome in-vitro research cell model and cryopreserved in liquid nitrogen, so that the foundation is laid for researching the pathogenesis of 18-trisomy syndrome for a long time from cell level in vitro.

Description

The gene constructed E trisomy cell model of transfection SV40LT and cell bank thereof
Technical field
The present invention relates to the structure of simian virus 40 large T antigen gene (SV40LT gene) transfection (mediation) E trisomy cell model and cell bank thereof, be mainly used in healthy reproduction research field, the research for E trisomy provides cell model and preserves its Scientific Research Resource.
Background technology
E trisomy belongs to one of great inborn defect, also name Edward's syndrome, namely patient is many No. 18 karyomit(e)s, this syndrome cardinal symptom shows as that patient's head has rear convex occipitalia, palpebral fissure is narrow and small, ear is lopsided, ear position low, micrognathia, breastbone are short and small.Because infant exists serious mental retardation companion Poly-monstrosity, 50% is dead in 2 months after birth, can live to 1 year less than 10%, can live 15 years old extremely individually.For want of effective treatment means, once infant birth brings spirit and economical load greatly will to family and society, has had a strong impact on the quality of the people of China, has become the heavy burden of social development and the serious hindrance of Sustainable development.
In recent years, E trisomy is classified as one of great inborn defect both at home and abroad, intervenes object as emphasis, and establish corresponding Prenatal Screening and methods for prenatal diagnosis.Emphasize in " 11th Five-Year Plan outline of national economy and social development ", the Intervention density of the inborn defects such as E trisomy be strengthened, to improve the health of newborns; In " National Program for Medium-to Long-term Scientific and Technological Development (2006-2020) ", the research of the inborn defects such as E trisomy is classified as preferential theme.
At present to the research of the inborn defects such as E trisomy mainly for the relation of heredity, biology, physics, chemical factor and morbidity (rate) and its early screening and diagnosis aspect, as there being a large amount of bibliographical informations abroad, the environmental factorss such as the generation of the inborn defects such as 18-tri-body and provincialism, Time to pregnancy, nuisance contact history are significant correlation; Have foreign literature to report, two identical recessive genes existing during consanguineous mating are relevant with giving birth to the inborn defect infants such as E trisomy; The body weight of the report such as Graaf, Rudnicka pregnant woman, smoking habit, final recognition are relevant with E trisomy screening indexes; The inborn defects such as Maternal Smoking Smoking, trace element, psychological factor, diet, torch infection etc. and E trisomy are relevant separately to have domestic scholars to report.
But, due to do not have can in vitro long-term cultivation, the immortality cell model that can be used for E trisomy study of incident mechanism and cell bank thereof, just be difficult to study from cell levels the mechanism such as transgenation, genetic expression, changing function, physiological property, biology conduction that E trisomy cell affects by physics, chemistry, biology, heredity etc. in vitro, thus seriously limit the further research of E trisomy.
Foreign literature is reported, simian virus 40 (SV40) can make some human cell that immortalization occurs.The research such as Poulin DL, Kung AL and Sullivan CS shows, the importing of SV40T antigen gene can accelerate the growth velocity of transformant, after immortalized cells repeatedly goes down to posterity in vitro, still there is metastable multiplication characteristic and functional status, also can retain many phenotypic differentiations of its initiating cell simultaneously, may be used for the foundation of the cell model of transgenic animal model and some kind of human and animal, the characteristic of initiating cell can be studied accordingly by means of research transgenosis immortalized cells and animal model in vitro, thus study its pathogenesis.
According to bibliographical information, vascular smooth muscle cell strain is set up in Reilly simian virus (SV40) large T antigen gene transformation, builds cell model to study the restraining effect mechanism of heparin for vascular unstriated muscle.Su etc. utilize the superficial cell strain transformed through SV40, build the regulating and controlling effect that cell model analyzes the synthesis of epithelial cell internal protein.The superficial cell strain that Miquel etc. transform with SV40, as the cell adhesion that cell model research ln 5 mediates.Webber etc. study physiological function and the secreting function of prostate epithelial cell as cell model with the prostate epithelial cell strain transformed through SV40.Racusen etc. transform with through Ad12-SV40 damage and the disease that proximal convoluted tubule studied by renal cells model.Hougton etc. transform with SV40 and set up Bone marrow Stromal cell as cell model to study under certain culture condition, and cell has the potential to adipocyte and osteoblastic two-way differentiation, further the osteoporotic mechanism of research.
Because of the needs of research work, almost often kind of disease all establishes respective cell model.As diabetes cell model, cancer cell model, transgenic cell model, climacteric syndrome cell model, endometrial cell model, epilepsy cell model, E-Cell models, alcoholic dementia cell model, cerebral edema cell model.Etc..
But, there is not yet so far and be used in the external bibliographical information studying the pathogenetic immortality cell model of E trisomy and cell bank thereof from cell levels about building, also cannot carry out relevant research project.
Summary of the invention
Be used in the external problem studying the pathogenetic immortality cell model of E trisomy and cell bank thereof from cell levels in order to solve to there is not yet so far about building, present inventors have proposed the present invention.
The object of the invention is the construction process that will provide with SV40LT gene transfection E trisomy cell model and cell bank thereof, another object is for providing SV40LT gene transfection E trisomy cell model and cell bank thereof from the pathogenesis of cell levels research E trisomy in vitro.
The object of the present invention is achieved like this: connect pcDNA3.1 (-) DNA and pcr amplification that cut through BamHI enzyme with T4DNA ligase enzyme simultaneously, the SV40LTag DNA that agarose gel electrophoresis is separated, build SV40LTag-pcDNA3.1 (-) recombinant plasmid, transform DH5a competent escherichia coli cell with amplification, purifying picking amp-R bacterium colony extracting plasmid, the E trisomy suspension histocyte or containing 20% foetal calf serum of going down to posterity digested through collagenase II is imported in vitro with lipofection, be in the nutrient solution of 5 ~ 10nmol/L Regular Insulin and will enter or just enter logarithmic phase, spindle cell accounts for more than 90%, converge the adherent growth E trisomy cell that rate reaches 55% ~ 65%, the DNA of recon and cell is integrated, with the cell of G418 screening containing positive recombinant, go down to posterity, enlarged culturing, screening cellular form, cell growth curve, karyotype, soft agarose growth test, nude mice tumorigenesis is tested, the large T gene test of SV40 in transfectional cell DNA, mrna expression product measures and determined dna sequence result meets immortalized cells characteristic and identical with primary cell or close person is frozen in liquid nitrogen as cell model, SV40LT gene transfection E trisomy cell model and cell bank thereof is built with this.
The SV40 large T antigen gene that the present invention purifies with pcr amplification, agarose gel electrophoresis imports E trisomy cell through genophore pcDNA3.1 and lipofection and builds its cell model, its histocyte digest with 0.01% collagenase II and need not be conventional tryptic digestion, digested or make cell suspension with the collagen only making to cause cytoadherence, the protein decreasing cell walls is digested and injure cell, makes the success ratio of cell cultures bring up to more than 95% by general about 85%; Select the defined medium containing 20mL/L foetal calf serum, 5 ~ 10nmol/L Regular Insulin, make cell can not grow too fast and affect the integration of SV40 large T antigen gene, also can not make because lacking nutrition or Growth of Cells stimulating factor cell do not meet the requirements of converge rate, do not enter logarithmic phase before with regard to premature death, or logarithmic phase shortens; Clone recovery cultivation after frozen 1 month in-196 DEG C of liquid nitrogen of preparation, all can grow attached cell; When making clone Chromosome Identification, the consumption of colchicine and action time are conventional 5 ~ 10 times, and chromosome separation is increased mutually, are enough to counting and analyze; The E trisomy cell model built up thus and cell bank thereof, for the pathogenesis studying E trisomy from cell levels in vitro lays the foundation.
Accompanying drawing explanation
Fig. 1 is 18 Trisomy cell model (adherent growth) figure prepared by the present invention.
As Fig. 1, passage to the 55th generation, be cultured to the 7th day time, rounded, fusiformis, to be paved with bottle at the bottom of, its Growth of Cells converges rate and reaches more than 95%, and after this along with the increase of passage number, Growth of Cells is slack-off, thinning to be dredged.
Embodiment
1, the extraction of SV40 large T antigen DNA: 1. SV40DNA enzyme is cut: the SV40 freeze dried powder or the SV40 plasmid that contain large T antigen gene from commercially available purchase, be dissolved in appropriate H 2in O or TE damping fluid, add 2uL10 × enzyme cutting buffering liquid and 18uL H 2o, adds restriction enzyme BamH I (1-5U/ugDNA), 37 DEG C of incubation 1h, 75 DEG C of heating 15min, and inactivator, adds 5uL electrophoresis sample loading buffer (also by adding 0.5mol/L EDTA) termination reaction in order to electrophoresis.2. SV40DNA electrophoresis: power taking swimming level agarose is made into 10% sepharose with electrophoretic buffer, pour on the gel casting platform sealed, plug sample comb, from glue platform removing envelope band after gelling is solid, extract comb, put into the electrophoresis chamber being added with enough electrophoretic buffers, damping fluid exceeds gel surface and is about 1mm, DNA sample is prepared with 10 appropriate × sample loading buffer, then with pipettor, sample is added in sample well, and do suitable DNA molecular amount standard control thing simultaneously, connect electrode, DNA anode is moved, when under the voltage of 1-10V/cm gel, electrophoresis is to the distance of enough isolation of DNA fragments, powered-down.3. from agarose, about 2600bp SV40 large T antigen DNA is separated: under 300-360nm long wave ultraviolet light source, (use long wave ultraviolet light source to prevent DNA damage) cut in loading dialysis tubing by the gel-tape containing target DNA fragments, 2ml electrophoretic buffer is added in dialysis tubing, make it submergence gel, and emptying steam bubble, dialysis tubing level is put into electrophoresis chamber (length direction is parallel with electrophoresis), add appropriate amount of buffer solution by dialysis tubing submergence (about 6-7mm), switch on power, 150 volts of electricity are washed, observe under ultraviolet lamp and treat that DNA all shifts out gel, change direction of an electric field and continue energising 1 minute, from dialysis tubing, sucking-off damping fluid is in 1-5ml Eppendorf pipe, add 1.5 times of volume propyl carbinols, EB is removed in mixing extracting, on desk centrifuge 2 minutes the most at a high speed, suck upper strata butanol solution, repetition secondary like this, equal-volume phenol chloroform (2) extracting 2 times is added in the solution of lower floor speech DNA, supernatant proceeds in another Eppendorf pipe and adds 1/10 times of volume 3M NaAc, 2 times of volume precooling dehydrated alcohols, spend the night in 20 DEG C, 12000g, at 4 DEG C centrifugal 10 minutes, obtain DNA precipitation, abandon supernatant, dry ethanol is abandoned after adding 70% washing with alcohol 2 times, add 50 μ l TE dissolving DNAs.In addition, also target DNA fragment is separated, is purified by available low melting-point agarose gel method, DNA filter membrane inserted sheet method etc. from gel.
2, the connection of SV40 large T antigen DNA and pcDNA3.1 genophore: get the above-mentioned DNA composition of 9 μ l (0.1-5 μ g), 10 μ l2 × connection damping fluids, 1 μ l10mmol/LATP, T4DNA ligase enzyme (20 ~ 500 sticky end unit) or e. coli dna ligase, pcDNA3.1 empty carrier mixes, 15 DEG C of incubation 24h, are built into SV40T/pcDNA3.1 recon.
3, the amplification of SV40T/pcDNA3.1 recon, Isolation and ldentification: the 1. preparation of E. coli competent: its basic skills is ice-cold CaCl 2or the process such as multiple divalent positively charged ion bacterium, making it to enter competence is transformed, and uses CaCl 2prepare fresh or freezing competent escherichia coli cell, be usually used in preparation in quantity competence bacterium, this law is applicable to most of coli strain, operating process is summarized as follows: cultivate picking single bacterium colony (as bacillus coli DH 5 2) the fresh plate of 16 ~ 20h from 37 DEG C, or 16 ~ 20h overnight culture that 1ml is fresh, forward one to containing in 1L or the 500ml flask of 100mlLB substratum, about 2 ~ 3h (rotary shaker 200 ~ 300r/min) is cultivated in 37 DEG C of violent joltings, OD600 value ≈ 0.4 is measured every 20 ~ 30min, aseptically bacterium is transferred to one, in ice-cold 50ml polypropylene centrifuge tube, 10 ~ 20min is placed on ice, in 4 DEG C with SorvallGS2 rotary head (or the rotary head matched with its centrifuge tube) with the centrifugal 10min of 4000r/min, to reclaim cell, nutrient solution reciprocal, pipe is inverted 1min to flow to end to make the trace nutrient solution of final residual, with the ice-cold 0.1mMCaCl of 10ml 2resuspended every part of precipitation, be put on ice, in 4 DEG C with SorvallGS3 rotary head (or its corresponding rotary head) with the centrifugal 10min of 4000r/min, to reclaim cell, pour out nutrient solution, pipe is inverted 1min to flow to end to make the trace nutrient solution of final residual, the 0.1M CaCl of every 50ml initial incubation thing 2ml ice precooling 2resuspended every part is sunk calmly, now, rapidly cell can be distributed into aliquot, freezing in liquid nitrogen,-70 DEG C of storages are for subsequent use, from every kind of competent cell suspension, getting 200 μ l with the sterile pipette tip of cooling transfers in aseptic Eppendorf tube, DNA or ligation mixture (volume≤10 μ l is added in every pipe, DNA≤50ng), rotate gently to mix content, 30min is placed in ice, centrifuge tube is put into pre-heating on the test-tube stand in the circulator bath of 40 DEG C, place 90s ~ 2min, do not shake test tube, fast pipe is transferred in ice bath, cell is made to cool 1 ~ 2min, every centrifuge tube adds 800 μ lSOC substratum, with water-bath, substratum is warmed to 37 DEG C, then pipe is transferred on 37 DEG C of shaking tables, incubation 45min makes bacteria resuscitation, and antibiotic-resistance marker's gene of expression plasmid coding, the competent cell that proper volume (each 90mm flat board can reach 200 μ l) has transformed is transferred to containing on 200mmol/LMgSO4 and corresponding antibiotic SOB substratum, flat board is placed in room temperature to be absorbed to liquid, be inverted plate, in 37 DEG C of cultivations, bacterium colony can be there is after 12 ~ 16h.2. the screening of recon, amplification and extraction: select single colony inoculation in the aseptic LB substratum of 5mL or rich medium (as super broth or TB super broth substratum) with sterile toothpick or disinfection inoculation pin, after overnight incubation, join 500mL again containing in the 2L flask of LB substratum (containing suitable microbiotic), then be cultured to state of saturation (OD in 37 DEG C 600≈ 4, for improving output, the flask of the comparatively large and band traverse baffle of surface-area should be adopted to increase venting quality as far as possible, jolting speed should be greater than 400r/min), in 4 DEG C, the centrifugal 10min of 6000g, by the resuspended precipitation of 4mL GTL solution, and transfer to (bacterial precipitation can be preserved at-20 DEG C or-70 DEG C of indefinitely) in the high speed centrifugation pipe of a volume>=20mL, add the GTE solution containing 25mg/mL N,O-Diacetylmuramidase that 1mL newly joins, resuspended precipitation, 10min is placed in room temperature, add 10mL and newly join NaOH/SDS solution, and mixing is until liquid becomes homogeneous gently, limpid and thickness, in placing 10min on ice, add 7.5mL acetic acid solution, stir until viscosity declines and forms large precipitation gently with suction pipe, in placing 10min on ice, in 4 DEG C, the centrifugal 10min of 20000g, supernatant is poured into gently in another clean centrifuge tube, if there is visible drift can by several layers of filtered through gauze, add the Virahol of 0.6 times of volume, put upside down mixing, room temperature places 5 ~ 10min, in room temperature, the centrifugal 10min of 1500g, add the washing precipitation gently of 2mL70% ethanol, then of short duration centrifugal fast, suck ethanol, and vacuum-drying (precipitation can be preserved for a long time at 4 DEG C).3. the qualification of recon: the above-mentioned DNA (containing recon SV40T/pcDNA3.1) extracted from competence intestinal bacteria, the same method restriction enzyme BamH I carries out enzyme and cuts, 10g/L agarose gel electrophoresis is identified, obtain 2 bands that size is about 2600bp and 5600bp, the former meets the size of SV40T fragment in GenBank.
4, the screening of SV40T/pcDNA3.1 recon transfection E trisomy histocyte and positive colony thereof and amplification: the 1. histiocytic collection of E trisomy and cultivation: with aseptic technique be extracted in do other test or other check after unnecessary, discarded E trisomy infant amniotic fluid cast-off cells, be about 1 × 10 with histocyte final concentration 5/ mL is for subsequent use, the cell got above-mentioned histocyte in single dispersion or become single dispersion is after treatment inoculated in containing 5 ~ 10nmol/L Regular Insulin, in the RPMI1640 liquid of 20% foetal calf serum or be inoculated in containing 20% foetal calf serum, in the low sugar DMEM cell culture medium of 5 ~ 10nmol/L Regular Insulin, be placed in 37 DEG C, in volume fraction 5%CO2 incubator, cell attachment is cultivated about 3 ~ 4 days, cellular form is fusiformis, little circular cell is less than 10%, the rate of converging of attached cell reaches 75% ~ 85%, be in when just entering logarithmic phase, namely consider to collect culturing cell, first blot the nutrient solution in clean culturing bottle, add the collagenase II liquid (can cover at the bottom of whole bottle with Digestive system and be as the criterion) of 1-2ml0.01%, leave standstill 2-10min (under microscope dynamic monitoring), suck collagenase II liquid, add low sugar DMEM or RPMI1640 nutrient solution, culture in glassware liquid is drawn with suction pipe, repeatedly blow and beat bottle parietal cell, form cell suspension, proceed to centrifuge tube centrifugation, remove supernatant liquor, after cell precipitation cleans 2 times with above-mentioned nutrient solution, make suspension, import as recon.2. the importing of SV40T/pcDNA3.1: method 1: in upper method Isolated cells, select lipofection, by above-mentioned 2 × 10 5individual cell is inoculated in 35mm culture dish, at 37 DEG C of CO 224 ~ 36h cultivated by incubator, make Hemapoiesis individual layer, cellular form be fusiformis, there is not yet or be rarely seenly less than 10% little circular cell, the rate of converging of attached cell reaches 55% ~ 65%, is in when entering or just entered logarithmic phase, namely transfection recon SV40T/pcDNA3.1 is considered, in 1.5ml Eppendorf tube, prepare following solution: i.e. pipe A, SV40T/pcDNA3.1 is dissolved in 100 μ l serum-free mediums; And pipe B, 20 μ l Lipofectamine are dissolved in 80 μ l serum-free mediums, mixed by pipe A and pipe B, the underlying 45min of room temperature, after sucking cell culture fluid, with serum-free medium washed cell 2 times, in Lipofectamine-SV40T/pcDNA3.1 mixture, add 1ml serum-free medium, mix gently, then drop in Tissue Culture Dish, then 1ml serum-free medium is added, at CO 210h cultivated by incubator, sucking-off transfection liquid, and add 4ml complete culture solution and continue to cultivate 16h, discard nutrient solution, changing concentration is 400mg ° of L -1g418 nutrient solution continue to cultivate, within 8 ~ 10 days, select individual cells colony to carry out subclone afterwards, strengthen 6418 concentration after enlarged culturing again to 800mg ° of L -1, in the G418 environment of high density, amplification of going down to posterity can be carried out by the clone of stable growth, in addition after E trisomy cell and SV40 or Epstein-Barr virus co-cultivation, infect viral DNA and the E trisomy cell occurring to integrate carries out amplification of going down to posterity.Method 2: draw 1/10-1/40 cell suspension, being mixed with final concentration is 1 × 10 5/ mL cell suspension, be inoculated in culturing bottle, select low sugar DMEM or RPMI1640 substratum, wherein containing 20mL/L foetal calf serum, 10nmol/L Regular Insulin, after cultivating 48h, make Hemapoiesis individual layer, cellular form is fusiformis, there is not yet or rarely seenly be less than 10% little circular cell, attached cell converges rate and reaches 55% ~ 65%, be in when will enter or just enter logarithmic phase, adopt the method for liposome transfection, by recon SV40T/pcDNA3.1 transfection in E trisomy cell, or by SV40 direct infection in E trisomy cell, with the liquid medium-selection 1wk containing 700mg/LG418, change G418 concentration into 300mg/L, to occurring positive colony, transfer them to new culturing bottle to expand, Secondary Culture, method 3: above-mentioned cell suspension is made into 5 × 10 with low sugar DMEM or RPMI1640 nutrient solution 8the cell suspension inoculation of/L final concentration in 24 well culture plates, until cell grow to about 90% merge time for transfection, its method is by the recon SV40T/pcDNA3.1 of 0.2 μ g content, with DMEM or RPMI1640 adjust volume be 50 μ l, room temperature place 5min, liposome 6 μ l, adjusting volume with DMEM is 50 μ l, room temperature places 5min, two kinds of reagent mix gently, room temperature places 20min, after cell DMEM in 24 orifice plates being washed 3 times simultaneously, add nutrient solution 100 μ l in every hole again, add liposome-SV40T/pcDNA3.1 mixed solution, gently cell surface paving evenly, 6h is placed in 37 DEG C of CO2 incubators, use 0.01g/L collagenase by cell dissociation subsequently, proceed in 6 orifice plates, add perfect medium, adding G418 microbiotic next day makes final concentration be 500mg/L, until there is monoclonal cell to grow.There is monoclonal cell colony to grow after about 10d, choose to be placed in 24 orifice plates and continue to cultivate, maintain and stabilize with the G418 of 300mg/L the amplification cultivation that goes down to posterity.E trisomy cell model is built with this.
5, the going down to posterity of E trisomy cell model, increase: collect the above-mentioned positive monoclonal cell colony importing SV40 large T antigen gene through lipofection, be made into about 1 × 10 with low sugar DMEM or RPMI1640 substratum 5the cell suspension of/mL, is inoculated in several bottles of 20 ~ 50cm 2in culturing bottle, add 5mL containing 20mL/L foetal calf serum, the low sugar DMEM of 10nmol/L Regular Insulin or RPMI1640 substratum, to cell attachment growth, converge rate reach 80 ~ 85%, be in the early stage of logarithmic phase time collecting cell, again by above-mentioned steps Secondary Culture, inoculation of repeatedly going down to posterity like this, cultivation, record algebraically and observation of cell growth characteristic.As Fig. 1, passage to the 55th generation, be cultured to the 7th day time, in logarithmic growth, circle, fusiformis, to be paved with bottle at the bottom of, its Growth of Cells converges rate and reaches more than 95%, and after this along with the increase of passage number, Growth of Cells is slack-off, thinning to be dredged.Wherein logarithmic growth refers to high cell growth speed, and the increase of cell quantity and incubation time are multiplication relation, when usually cultivating by kind of a cell routinely, cultivates the individual cells that just can find growth for 1 ~ 2 day under the microscope; Visible cell colony when 4 ~ 5 days, at the bottom of adherent growth cell bedding culturing bottle 1/3, at the bottom of visible adherent growth cell bedding culturing bottle more than 2/3 when cultivating 7 ~ 13 days, even cell overlap, interspace hardly (converge rate and reach 95 ~ 100%), cell light, without particle, without catabiosis such as harsh feelings, also can judge according to the relation of cell counting and incubation time; Dead cell is few, and cause death and floating cell are less than 10% [differentiate dead cell and viable cell by trypan blue staining, because normal viable cell, after birth structural integrity, can repel, and trypan blue can not be entered in born of the same parents weekly; And the cell of loss of activity, the permeability of after birth increases, blueness can be dyed by trypan blue, can be judged as that cell is dead, method draws weekly a certain amount of suspension culture, mixes rearmounted room temperature 5 ~ 10 minutes, then make cell sheet with Trypan Blue agent, count 1000 total cellular score under the microscope, calculate the per-cent of painted dead cell and non-staining viable cell].
6, the qualification of E trisomy cell model biological characteristics: after using SV40 to set up cell model (clone), the key issue of qualification has: one is that this cell of requirement has lasting multiplication capacity, i.e. T antigen stably express in clone; Two are its forms of requirement, basic physiological function isophenous remains unchanged.Whether 1. observation of cell form: every day, whether observation of cell was in typical epithelial cell sample adherent growth under inverted light microscope is fusiformis or the growth of little circular; 2. observation of cell growth curve: get the good transfectional cell of growth, adopts 0.25 trypsin solution digestion, makes cell suspension, through counting, get 1.4 × 10 respectively 4cell is inoculated in 30 containing 15FBS low sugar DMEM culture medium culturing bottle.Get 2 bottles of cells every day to count, computation of mean values, Continuous Observation, until cell quantity obviously declines, is cultivated after 3 days and was changed liquid every 2 days to the cell of no count, adopts same method to observe the growing state of transfectional cell in hepato ZYME-SFM serum free medium.Result take incubation time as transverse axis, and cell quantity is the longitudinal axis (logarithm), be depicted in semi-logarithmic scale to make after curve the growth curve of this cell, immortalized cell line is formed in typical " S " feature or " arched roof "; 3. karyomit(e) is checked: if karyotype is 47, XX ,+18; Or 47, XY ,+18; Or be same as the primary 18 Trisomy cells of the present invention's collection, then illustrate that this clone vicious transformation does not occur and (whether occurs abnormal DNA colony in available flow cytometry analysis clone simultaneously, if no, also illustrate that knurl feature does not appear in clone).Chromosome karyotype analysis method is: reach 85-95% (its medium and small circular cell accounts for 10%) at cell density, to be in the culture of logarithmic phase in by 5mL nutrient solution the 250ug/ml colchicine 100ul adding preheating, mix rearmounted 37 DEG C of incubators 4 hours, blot nutrient solution, add the 2-3mL EDTA-trysinization liquid of preheating, 37 DEG C act on 5 minutes, stop digestion, wash lower attached cell, through centrifugal, hypotonic, fixing, film-making, G aobvious band post analysis karyotype; 4. soft agarose growth test: by the cell of immortalization after SV40T transfection with 5 × 10 4it is in 35mm soft agar plate that/ml is inoculated in diameter, after observing three weeks, does not find Clone formation, illustrates that the SV40T immortalization chromosome abnormalty amniocyte of this experiment can not form clone in soft agar, meets immortalization feature; 5. nude mice tumorigenesis test: by the cell of SV40T immortalization with 3 × 10 7inoculation nude mice dorsal sc, after 2 months, 4 nude mices are showed no tumour and are formed, and prove that this cell is non-malign cells; 6. the large T gene test of SV40 in transfectional cell DNA: as with Immunohistochemical detection, in the nucleus of SV40 transfection, the visible a large amount of brown particle of dyeing, shows that SV40T antigen has been integrated in cell; Also the expression of T antigen in cell can be detected by RT-PCR method, the wherein primer of T antigen: upstream primer (A4239) 5 '-GTT ATG ATT ATA ACT GTTATG-3 ', downstream primer (S4496) 5 '-GAA ATG CCA TCT AGT GAT-3 '; Amplified production length is 268bp, and amplification condition is 94 DEG C, 5min, that is: and (94 DEG C, 1min; 55 DEG C, 1min ,-0.5 DEG C/circulation; 72 DEG C, 1min) × 30, (94 DEG C, 30S; 40 DEG C, 30S, 72 DEG C, 30S) × 15, amplification system is 50 μ l:[Mg 2+] 2mmol/L, dNTPs200 μm ol/L, primer concentration 0.4 μm of ol/L, Taq1U, template 5 μ l; Experimental group with the 19th generation cell cDNA for template (with reference to commercially available cDNA first chain synthetic agent box carry out cDNA first chain synthesis, product-20 DEG C preservation); Negative control establishes two, template is done respectively with the cDNA of sterilized water, primary cell, positive control is that template (extracts SV40DNA with reference to SDS-proteinase-K pathway with SV40DNA, because SV40 virus is without coating, do not use SDS rupture of membranes, get 5 μ l and carry out 1.5% agarose gel electrophoresis detection, all the other-20 DEG C save backup); 7. mrna expression product measures: T antigen mRNA RT-PCR product checks order: the amplified production getting 100 μ l systems, test kit (Takara is reclaimed with gel, Japan) reclaim product, get 2 μ l DNA solutions and dilute 100 times, survey concentration, remaining DNA and each 10 μ l of upstream and downstream primer checks order.4. Flow cytometry: the cell proportion detecting synthesis in the 19th continuous cell line, division, if its multiplication capacity obviously strengthens than not building the normal cell being, explanation is the result that SV40 large T antigen is integrated, expressed; 8. determined dna sequence: sequenator detects routinely, display SV40 large T antigen DNA sequence dna.
So cell model of the present invention is that 1. cell is the epithelial cell sample adherent growth of fusiformis or little circular under inverted light microscope; 2. the growth curve of cell is as taken incubation time as transverse axis, and cell quantity is the longitudinal axis, is that " S " feature or " arched roof " are formed in hepato ZYME-SFM serum free medium; 3. karyotype is 47, XX ,+18; Or 47, XY ,+18; Or be same as the original Down's syndrome cell of the present invention's collection; 4. cell can not grow (forming clone) in soft agar; 5. cell is non-malign cells, nude mice tumorigenesis negative; Incorporate SV40T antigen gene in the DNA of 6. cell, express SV40T antigen mRNA product; 7. passage to the 55th generation, be cultured to the 7th day time, in logarithmic growth, circle, fusiformis, to be paved with bottle at the bottom of, its Growth of Cells converges rate and reaches more than 95%, and after this along with the increase of passage number, Growth of Cells is slack-off, thinning to be dredged.
7, SV40LT gene transfection E trisomy cell model and cell bank thereof: screen and continue to go down to posterity, enlarged culturing meets immortalized cells characteristic and the cell identical or close with primary cell after above-mentioned qualification, get the attached cell that growth conditions is good, be in the different generations of logarithmic phase, through digestion, stop and centrifugation (1200r/min, 6min), with the frozen storing liquid 0.5 ~ 1ml re-suspended cell containing methyl-sulphoxide, cell density is 5 × 10 5individual/ml, adds cryopreservation tube, through 4 DEG C, and 0.5h,-20 DEG C, 2h,-70 DEG C, spend the night, enter-196 DEG C of liquid nitrogen cryopreservations, build the stable immortalization E trisomy cell model of biological characteristics and cell bank thereof in this way, with concentrated preservation genetic resources, for other researchs provide scientific research material, again can directly as the cell model of E trisomy pathogenesis in vitro study, to accelerate the new way expanding E trisomy research, E trisomy cell is studied in vitro by physics from cell levels, chemistry, biological, heredity waits the transgenation of impact, genetic expression, changing function, physiological property, the mechanism such as biological conduction.
8, cell model application
1) cell model is as scientific research cell
18 heterotrimeric cell models are made to be in the artificial nuisance with different content or concentration manufactured as physics (as X-ray), chemistry is (as formaldehyde, gasoline, plumbous, mercury), biological (as rubella virus, cytomegalovirus, simplexvirus) condition under cultivate, then the viable cell of the different cycles of external Long Term Passages is got, the apoptotic cell of succeeding generations, nutrient solution containing the meta-bolites produced in Secondary Culture from different perspectives and level, research chromosome abnormalty, other are abnormal, normal control cells model is to the tolerance of nuisance, nuisance causes the mechanism of inborn defect.Such as apply ordinary method as gene chip, miRNA chip, comparative genomic hybridization hybrid chip (CGH), differential methylation hybridization hybrid chip (DMH) and SNPs, etc. screen the gene of difference and polymorphism, methylation level, the gene rate of rotation in the technology for detection gene place such as in situ hybridization (FISH), Northern blot, Real-time PCR, CHIP, EMSA research cell model is used to express, locate and regulation and control, utilize the meta-bolites of protein metabolism process and key in enzyme reaction, metabonomic technology identification of cell model Long Term Passages, application two-dimensional electrophoresis, MALDI-TOF Mass Spectrometric Identification, the protein function of the technical study such as yeast two-hybrid and co-immunoprecipitation cell model in Long Term Passages and the interaction between protein, dynamic from viable cell culturing process, the bad environmental factor that studies for a long period of time causes the mechanism of inborn defect, such as: 1. common in environment toxicant benzopyrene causes the research of 18 3 body inborn defects: make 18 heterotrimeric cell models and normal control cells contain 0.1 respectively, 1.0, 5.0, 10.0, cultivate in the nutrient solution of 20.0pmol/L benzopyrene, detect cultivation 2 weeks, 4 weeks, 6 weeks, 8 weeks, the apoptosis that can be used as cytotoxicity index of the different incubation time such as 16 weeks, downright bad, dikaryocyte rate and the micronuclear rates that can be used as genetoxic index, caryoplasm bridge rate, core bud rate, namely the micronucleus number in 10000 dikaryocytes is counted under an optical microscope, caryoplasm bridge number and core bud number, necrosis and apoptosis cell count in 500 viable cell, dikaryocyte number, and detection cell survival rate, namely tetrazolium-based colorimetric assay (mtt assay) is applied, after sucking original fluid, 96 orifice plates add the serum-free medium of the 5mg/mlMTT of 20%, continue to cultivate 4h, supernatant liquor in hole is abandoned in careful suction, every hole adds 150 μ L methyl-sulphoxides, vibration 10min, purple crystal thing is fully dissolved, and this microplate reader measures the absorbance in each hole with 490nm, calculates cell survival rate.Can also other normal experiment methods detect different incubation time containing toxic substance with containing the transgenation, proteomics, emiocytosis function, chromosome aberration, cell survival rate (life-span) etc. of respectively organizing cell in toxic substance, case and normal cell, with from viable cell culturing process from the mechanism that cell levels is dynamic, the bad environmental factor that studies for a long period of time causes 18 3 body inborn defects.2. replace toxicant benzopyrene with certain sex pheromone and do same research, can from the mechanism that cell levels is dynamic, the biotic factor that studies for a long period of time causes 18 3 body inborn defects from viable cell culturing process.3. by the medicine being made into concentration gradient be made into the sex pheromone of concentration gradient or poisonous chemical substance and 18 heterotrimeric cell model co-cultivation, can from viable cell culturing process from cell levels dynamically, the medicine that studies for a long period of time is to causing the result for the treatment of of 18 3 body inborn defect factors and the intervention effect to inborn defect.4. the method for available equally 18 heterotrimeric cell model research gene therapies, substitutes some and directly does experiment with human body.
2) cell model is as Quality Control cell
The quality control in laboratory is the access system of carrying out laboratory diagnosis project, becomes action by government.18 heterotrimeric cell models can be used as Quality Control cell, comment for Internal Quality Control and room interstitial.The chromosomal disorder laboratory diagnostic methods of clinical samples is such as synchronized with cell model, make regular growth cultivation, karyomit(e) preparation, chromosome karyotype analysis, to examine the reagent quality, instrument performance, working method etc. of experimentation whether reliable, be equivalent to the positive, the negative control in testing; By cell model after the image that routine chromosome preparation, chromosome karyotype analysis obtain arranges, each laboratory can be sent to, to examine each room to the accuracy of the diagnosis of various chromosome abnormalty image; Cell model can be sent to each laboratory, Result after each room makes regular growth cultivation, chromosome sectioning, chromosome karyotype analysis voluntarily, External quality evaluation is done to the diagnostic result of each room, by appraising through comparison the accuracy of each room, to find associated problem, deal with problems, to improve quality of diagnosis; 18 heterotrimeric cell models can be mixed in the kind required for Quality Control and ratio with various normal dyeing somatocyte, make the mixing Quality Control cell containing different sorts and ratio, numerical abnormalities of chromosomes Internal Quality Control cell is detected and room interstitial comments cell as fluorescence in situ hybridization (FISH), if certain laboratory is being done not detect different types of chromosome abnormalty of (failing to pinpoint a disease in diagnosis) Quality Control cell in FISH, accurately do not detect the ratio (%) of different types of chromosome abnormalty, then there are quality problems in illustrative experiment method, and reason should be looked for correct.Now be described as follows with the example that has particular application as of Quality Control cell in fluorescence in situ hybridization room interstitial is commented of preparation after the mixing of several chromosome abnormalty cell model: 1. prepare Quality Control cell: get 1 example or numerical example 18 3 body and karyomit(e) normal cell model, mix Quality Control cell in the example required for Quality Control time or ratio, the Quality Control cell of mixing also can use through amplification after discharge.As mixed with 1 routine karyomit(e) normal cell model equal proportion cell count with 1 example 18 3 Autosome number abnormal cells model, then the cell of 18 3 Autosome number exceptions and karyomit(e) normal cell respectively account for 50%.Then Quality Control cell is sent to each study subject and does External quality evaluation.2. fluorescence in situ hybridization (FISH) detects Quality Control cell chromosome number and result judgement: after each study subject receives Quality Control cell, and can going down to posterity to Quality Control cell strain as one sees fit, amplification is rear to be tested, to increase cell count.Reagent adopts the AneuVysion test kit of Abbott GmbH. & Co. Kg of Switzerland, complete 3 articles of chromosomal number analyses: No. 18 (Spectrum Aqua, cyan), X (Spectrum Green, green), Y (Spectrum Orange, red) number karyomit(e) is counting oligonucleotide (ChromosomeEnumerating Probe, CEP), hybridization the 1st region after mixing, method gets 18, X and Y chromosome probe, by synchronous for Quality Control cell (sample tested with laboratory), through the centrifugal 10min of 2000r/min, remove supernatant, stay precipitation 0.2ml, 4ml collagenase 37 DEG C temperature bath 30min is added in centrifuge tube, the centrifugal 10min of 2000r/min, remove supernatant, then the 15mol/L KC1 of the pre-temperature of 5ml is added, hypotonic 25min in 37 water-baths, the centrifugal 10min of 2000r/min, remove supernatant.Add the fixing 10min of stationary liquid (methyl alcohol: Glacial acetic acid=3:1) of new preparation, centrifugal 2000r/min is centrifugal, and 10min removes supernatant, twice repeatedly.Drip sheet, seasoning is aging.Taken out in refrigerator-freezer by the sample slice prepared, put successively in people 70%, 85%, 100% ethanol and dewater, drying at room temperature, the slide that pre-treatment is good puts 73 DEG C, 5min in 70% methane amide.Two kinds of each 10 μ l of probe mixed solution are added in the target region of slide in darkroom, covered, avoid producing bubble, cover glass is sealed by mounting glue, put 42 DEG C of hybridized overnight in dark wet box, cleaning, at high power Microscopic observation crossbreeding effect, every routine sample counting 60 ~ 100 cells, record hybridization signal number also gathers image, require that nuclear membrane must be complete, hybridization signal zero lap limpid in sight in core, signal disperse and faintly all not take statistics.3. test result: after probe hybridization, the point of intracellular No. 18 karyomit(e)s display cyan, the point of No. 18, every bar display 1 cyan, 2 points then showing 2 cyans, 3 points then showing 3 cyans; The point that in cell, the display of X (women) karyomit(e) is green, every bar X chromosome shows 1 green point, 2 points that then display 2 is green, 3 points that then display 3 is green; The point that in cell, the display of Y (male sex) karyomit(e) is red, every bar Y chromosome shows 1 red point, 2 points that then display 2 is red, 3 points that then display 3 is red.If experimenter's technology, operation, experiment equipment, reagent etc. are defective in quality, then in the point of No. 21 karyomit(e) redness, cell, in the point of X (women) karyomit(e) green, cell, the point of Y (male sex) karyomit(e) redness does not just have signal or is difficult to recognize.4. in addition, case cell model can be used for the positive control of the technique of gene detection such as gene chip, miRNA chip, comparative genomic hybridization hybrid chip (CGH), differential methylation hybridization hybrid chip (DMH) and SNPs, Northern blot, Real-time PCR, CHIP, EMSA, or as case resource conservation, standby effect aforesaid method does the detections such as transgenation, genomics, proteomics, to analyze pathogeny.

Claims (7)

1. one kind for the SV40LT gene transfection E trisomy cell model of medical research field and the structure of cell bank thereof, its principal character is routinely with T4DNA ligase enzyme, BamHI, pcDNA3.1 (-) DNA and SV40LTag DNA builds SV40LTag-pcDNA3.1 (-) recon, with competence intestinal bacteria purification of Recombinant, imported through going down to posterity of digesting of collagenase II or in the E trisomy histocyte of logarithmic growth in vitro with lipofection, the DNA of recon and cell is integrated, and enlarged culturing is through the cell clone of G418 screening containing positive recombinant, screening cellular form, growth curve, karyotype, soft agarose grows, nude mice tumorigenesis is tested, the large T gene test of SV40 in transfectional cell DNA, mrna expression product measure and determined dna sequence result meet immortalized cells characteristic and identical with primary cell or close person to mediate E trisomy in vitro study cell model as SV40LT antigen gene frozen in liquid nitrogen, for laying the foundation from study for a long period of time the pathogenesis of E trisomy of cell levels in vitro.
2. the structure of SV40LT gene transfection E trisomy cell model according to claim 1 and cell bank thereof, is characterized in that indication cell model (1) cell is the epithelial cell sample adherent growth of fusiformis or little circular under inverted light microscope; (2) growth curve of cell is as taken incubation time as transverse axis, and cell quantity is the longitudinal axis, is that " S " feature or " arched roof " are formed in hepato ZYME-SFM serum free medium; (3) karyotype is 47, XX (XY) ,+18; (4) cell can not grow (not forming clone) in soft agar; (5) cell is non-malign cells, nude mice tumorigenesis negative; (6) incorporate SV40LT gene in the DNA of cell, express SV40LTmRNA product; (7) passage to the 55th generation, be cultured to the 7th day, still in logarithmic growth, circle, fusiformis; (8) be used for studying the pathogenesis of E trisomy, genetic resources storage, experiment contrast and Quality Control cell from cell levels (substitute human body or animal straightway testing) in vitro as cell model.
3. the structure of SV40LT gene transfection E trisomy cell model according to claim 1 and cell bank thereof, it is characterized in that taking from gathers because other experiments are required and E trisomy infant amniotic fluid cast-off cells that are unnecessary after other experiments, that discard build it.
4. the structure of SV40LT gene transfection E trisomy cell model according to claim 1 and cell bank thereof, is characterized in that nutrient solution used is the RPMI1640 containing 20% foetal calf serum, 5 ~ 10nmol/L Regular Insulin or the low sugar DMEM nutrient solution containing 20mL/L foetal calf serum, 5 ~ 10nmol/L Regular Insulin.
5. the structure of SV40LT gene transfection E trisomy cell model according to claim 1 and cell bank thereof, it is characterized in that being used as Secondary Culture imports recon E trisomy histocyte in order to lipofection, in primary amplification cultivation, its collect index be cell attachment cultivate about 3 ~ 4 days, cellular form is fusiformis, little circular cell less than 10%, the rate of converging of attached cell reaches 75% ~ 85%, is in collecting cell when just entering logarithmic phase; Import the E trisomy histocyte that goes down to posterity of recon as lipofection, the index of its choose opportunities is cellular form be fusiformis, there is not yet or be rarely seenly less than 10% little circular cell, the rate of converging of attached cell reaches 55% ~ 65%, is in culturing cell when entering or just entered logarithmic phase; The index that continuous cell line is collected be select cell attachment growth converge that rate reaches 80 ~ 85%, collecting cell when being in the early stage of logarithmic phase; The cell harvesting index of chromosome karyotype analysis is that cell density reaches 85-95%, little circular cell accounts for more than 10%, is in the cell of logarithmic phase.
6. the structure of SV40LT gene transfection E trisomy cell model according to claim 1 and cell bank thereof, it is characterized in that the E trisomy histocyte digesting adherent growth with 0.01% collagenase II, when making chromosome karyotype analysis, add 250ug/ml colchicine 100ul in every 5mL nutrient solution, mix rearmounted 37 DEG C of incubators 4 hours.
7. the structure of SV40LT gene transfection E trisomy cell model according to claim 1 and cell bank thereof, is characterized in that the structure of cell bank comprises (1) screening and meet immortalized cells characteristic and the E trisomy cell of the SV40LT gene transfection identical or close with primary cell after qualification; (2) go down to posterity, enlarged culturing, get the attached cell that growth conditions is good, be in the different generations of logarithmic phase; (3) through digestion, termination, centrifugal (1200r/min, 6min) step harvested cell; (4) preparing density with the frozen storing liquid containing methyl-sulphoxide is 5 × 10 5the cell suspension of individual/ml; (5) according to 4 DEG C, 0.5h;-20 DEG C, 2h;-70 DEG C, spend the night; Enter the program freeze-stored cell of-196 DEG C of liquid nitrogen; (6) recyclability ground is long-term preserves SV40LT gene transfection E trisomy cell model, for making genetic resources and scientific research material.
CN201310415253.0A 2013-09-01 2013-09-01 Construction of 18-trisomy syndrome cell model and cell bank of 18-trisomy syndrome cell by SV40LT gene transfection Pending CN104419684A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310415253.0A CN104419684A (en) 2013-09-01 2013-09-01 Construction of 18-trisomy syndrome cell model and cell bank of 18-trisomy syndrome cell by SV40LT gene transfection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310415253.0A CN104419684A (en) 2013-09-01 2013-09-01 Construction of 18-trisomy syndrome cell model and cell bank of 18-trisomy syndrome cell by SV40LT gene transfection

Publications (1)

Publication Number Publication Date
CN104419684A true CN104419684A (en) 2015-03-18

Family

ID=52969808

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310415253.0A Pending CN104419684A (en) 2013-09-01 2013-09-01 Construction of 18-trisomy syndrome cell model and cell bank of 18-trisomy syndrome cell by SV40LT gene transfection

Country Status (1)

Country Link
CN (1) CN104419684A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108277196A (en) * 2018-01-19 2018-07-13 武汉大学 A kind of plasmid DNA transfection method of high-efficiency low-toxicity

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1609194A (en) * 2003-10-25 2005-04-27 翁炳焕 Chromosome abnormality quality controlling cell preparation and the quality control method
CN101942413A (en) * 2009-07-07 2011-01-12 翁炳焕 Birth defect cell bank and construction method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1609194A (en) * 2003-10-25 2005-04-27 翁炳焕 Chromosome abnormality quality controlling cell preparation and the quality control method
CN101942413A (en) * 2009-07-07 2011-01-12 翁炳焕 Birth defect cell bank and construction method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
汪廷乐 等: "人永生细胞系模型建立的方法", 《上海口腔医学》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108277196A (en) * 2018-01-19 2018-07-13 武汉大学 A kind of plasmid DNA transfection method of high-efficiency low-toxicity
CN108277196B (en) * 2018-01-19 2020-10-13 武汉大学 High-efficiency low-toxicity plasmid DNA transfection method

Similar Documents

Publication Publication Date Title
CN101942413B (en) Birth defect cell bank and construction method thereof
CN103667176B (en) Carassius auratus gibelio brain tissue cell line sensitive to cyprinid herpesvirus II, and establishing method and application thereof
CN101591638B (en) Method for constructing kidney cell line of scophthalmus maximus
CN103881975B (en) Human Prostate Cancer Cells and primary separation and Culture thereof and Secondary Culture method and purposes
CN111534476B (en) Method for dissociating and separating spermatids of shellfish spermary
CN104419676A (en) Construction of down's syndrome cell model and cell bank of down's syndrome cell by employing hTERT gene recombination
CN104419684A (en) Construction of 18-trisomy syndrome cell model and cell bank of 18-trisomy syndrome cell by SV40LT gene transfection
CN104060329A (en) Immortalized quality-control cell bank for chromosome karyotype analysis and construction method thereof
CN111759864B (en) Application of amniotic fluid stem cells in preparation of medicine for treating lupus nephritis
CN104419677A (en) Construction of trisomy 18 syndrome cell model and cell bank thereof by hTERT transgenosis
CN104419682A (en) Construction of trisomy 21 syndrome cell model and cell bank thereof by using recombined SV40LT and hTERT genes
CN103667192B (en) Atypical chronic myeloid leukemia cell line and preparation method thereof
CN104419665A (en) SV40LT-mediated down syndrome cell model and construction method of cell bank thereof
CN104419664A (en) Construction of Turner syndrome cell model and cell bank of Turner syndrome cell by SV40T gene induction
CN104419669A (en) Building of klinefelter syndrome cell model and cell bank of klinefelter syndrome cell by virtue of recombinant SV40 gene
CN104419671A (en) Congenital heart disease atrial septal defect cell model and cell bank thereof established by inducing SV40 large-T genes
CN104419678A (en) Method for constructing cell model and cell bank for Edward syndrome by mediation of hTERT (human Telomerase Reverse Transcriptase) and SV40LT recombinants
CN104419672A (en) Congenital heart disease ventricular septal defect cell model constructed by transduced SV40LT antigen gene and cell bank thereof
CN104419727A (en) Construction of neural tube defect cell model and cell bank thereof under induction of hTERT recombinant
CN104059882A (en) Fluorescence in situ hybridization hTERT transfected external quality assessment cell line and preparation method thereof
CN104419666A (en) Construction of chromosome translocation cell model and cell bank thereof by virtue of transfection of monkey kidney virus 40 capital T genes
CN104419679A (en) Construction of Klinefelter's syndrome cell model and cell bank of Klinefelter's syndrome cell by hTERT and SV40LT gene induction
CN104419673A (en) Method for constructing cell model and cell bank for Klinefelter syndrome by transfecting hTERT (human Telomerase Reverse Transcriptase) recombinant gene
CN104419681A (en) Construction of Turner syndrome cell model and cell bank of Turner syndrome cell by SV40LT and hTERT gene transduction
CN104419667A (en) Construction of neural tube defect cell model and cell bank of neural tube defect cell by importing SV40T gene

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20150318